Episode 854 • • 59:13 - 1:05:57
854: Premedicated
Ranbaxy Generic Drug Scandal and Clinton Foundation Ties
The Clinton Foundation's HIV/AIDS initiative is linked to Ranbaxy, an Indian generic drug manufacturer that paid a $500 million fine to the FDA for selling adulterated drugs. Charles Ortel and Fortune magazine's "Dirty Medicine" report suggest the foundation promoted these untested drugs in Africa despite internal warnings about their quality. The hosts argue the foundation acted as a "business development" arm for the company rather than a traditional charity.